#+Title: Mitochondria Disease
#+options: title:nil toc:nil num:nil author:nil date:nil
#+latex_class: article
#+latex_class_options:[landscape]
#+latex_header: \usepackage{longtable}
#+latex_header: \usepackage[margin=0.45in]{geometry}
#+latex_header:
#+latex_header_extra:
#+description:
#+keywords:
#+subtitle:

#+CAPTION[]: Mitochondrial Disease
#+NAME: tab:mtdna
#+ATTR_LATEX: :environment longtable :float sideways
| Syndrome      | Phenotype                                           | Onset        | Molecular                           | Labs                                          |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| CoQ           | Multi-system with neurologic manifestations         | Neonatal     | AR :: 10 CoQ and assembly genes     | \uparrow L/P(B,C)                             |
|               | fatal neonatal encephalopathy, hypotonia            |              |                                     | \downarrow CoQ(T)                             |
|               | late-onset slowly progressive                       | Childhood    |                                     | \downarrow combined CI + CIII activity(T,F)   |
|               | multiple-system atrophy                             |              |                                     | \downarrow combined CII + CIII activity(T,F)  |
|               |                                                     |              |                                     | N individual CI, CII, CII activity(T,F)       |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| MDDS          | hepatocerebral disease, progressive myopathy        | Neonatal     | AR :: POLG, twinkle, TK2, DGUOK,    | \uparrow L/P(B,C), \uparrow MMA[fn:mma]       |
|               |                                                     | Infancy      | SUCLA2, SUCLG1                      | \uparrow thymidine, deoxyuridine(U,P)[fn:tk2] |
|               |                                                     |              |                                     | \downarrow mtDNA(T)                           |
|               |                                                     |              |                                     | \downarrow CI, CIII, CIV activity (T,F)       |
|               |                                                     |              |                                     | N/\uparrow CII activity (T,F)                 |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| Pearson       | Exocrine pancreatic dysfunction,                    | Infancy      | mtDNA :: deletion                   | \uparrow L/P(B,C)                             |
|               | sideroblastic anemia                                |              |                                     | mtDNA del/dup(T,U)                            |
|               |                                                     |              |                                     | \downarrow CI, CIII, CIV activity (T,F)       |
|               |                                                     |              |                                     | RRF, COX -ve, SDH +ve(T)                      |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| MEGDEL        | 3-Methylglutaconic aciduria, deafness,              | Infancy      | AR :: SERAC1                        | \uparrow L/P(B)                               |
|               | encephalopathy and Leigh-like disease               |              |                                     | \uparrow 3-MGA, 3-MGC(U)                      |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| KSS           | Ophthalmoplegia, RP,                                | Childhood    | mtDNA :: deletion                   | \uparrow L/P(B,C)                             |
|               | cardiac conduction block,                           |              |                                     | mtDNA del/dup(T,U)                            |
|               | diabetes, short stature, myopathy                   |              |                                     | \downarrow CI, CIII, CIV activity (T,F)       |
|               |                                                     |              |                                     | RRF, COX -ve, SDH +ve(T)                      |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| Leigh         | Psychomotor delay, dystonia, seizures,              | Infancy      | mtDNA :: MT-ATP6 and others         | \uparrow/N L/P(B,C)[fn:pdh]                   |
|               | subacute necrotising encephalopathy,                | Childhood    | AR :: SURF1, SDHA, COX assembly, CI | mtDNA del/dup(T,U)                            |
|               | bilateral symetrical lesions on MRI,                |              | XL :: PDHA1 (PDHC E1\alpha subunit) | N\downarrow CI, CIII,CIV activity (T,F)       |
|               | hypotonia, ataxia, optic  atrophy,                  |              | mtDNA :: deletion                   | RRF,COX -ve, SDH +ve(T)                       |
|               | short stature, respiratory abnormalities            |              |                                     |                                               |
| NARP[fn:narp] | Peripheral neuropathy, ataxia, RP                   | Childhood    | mtDNA :: MT-ATP6                    |                                               |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| MNGIE         | Neuro-gastrointestinal encephalopathy               | Childhood    | AR :: TYMP                          | \uparrow L/P(B,C)                             |
|               |                                                     |              |                                     | \uparrow thymidine, deoxyuridine(U,P)         |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| MELAS         | Metabolic stroke, seizures, psychomotor regression, | 2-40 yrs     | mtDNA :: MT-TL1, MT-ND5             | \uparrow L/P(B,C)                             |
|               | cortical blindness, sensorineural hearing loss,     |              |                                     | \downarrow CI activity (T,F)                  |
|               | muscle weakness, short stature                      |              |                                     | RRF, COX +ve, SDH +ve(T)                      |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| LHON          | Optic neuropathy                                    | Adolescence- | mtDNA :: MT-ND1, MT-ND4, MT-ND6     | \uparrow L/P(B,C)                             |
|               |                                                     | Adult        |                                     | \downarrow CI activity (T,F)                  |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| MIDD          | Diabetes, sensorineural hearing loss                | Adolescence- | mtDNA :: MT-TL1                     | \uparrow L/P(B,C)                             |
|               |                                                     | Adult        |                                     |                                               |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| MERRF         | Seizures, ataxia, myoclonus, muscle weakness        | Adolescence- | mtDNA :: MT-TK                      | \uparrow L/P(B,C)                             |
|               | sensorineural hearing loss,  lipomatosis            | Adult        |                                     |                                               |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|
| CPEO          | Ophthalmoplegia, ptosis                             | Adult        | mtDNA :: deletion                   | \uparrow L/P(B,C)                             |
|               |                                                     |              |                                     | mtDNA del/dup(T,U)                            |
|               |                                                     |              |                                     | \downarrow CI, CIII, CIV activity (T,F)       |
|               |                                                     |              |                                     | RRF, COX -ve, SDH +ve(T)                      |
|---------------+-----------------------------------------------------+--------------+-------------------------------------+-----------------------------------------------|

- Abbreviations :: RP, retinitis pigmentosa; U, urine; UOA, urine organic acids; P, plasma; B, blood; C, CSF; T, tissue; F, fibroblasts
- Genes
  - MT-TP :: tRNA^{Pro}
  - MT-TL1 :: tRNA^{Leu(UUR)}
  - MT-TK :: tRNA^{Lys}
  - MT-ND1 - MT-ND6 :: CI
  - MT-ATP6 :: CV
  - SURF1 :: regulation of cytochrome c oxidase assembly
  - Twinkle :: mtDNA helicase
  - POLG :: polymerase \gamma
  - TYMP :: thymidine phosphorylase
  - TK2 :: thymidine kinase
  - DGUOK :: deoxyguanosine kinase
  - SUCLA2/SUCLG1 :: succinyl-CoA ligase 
  - RRM2B :: ribonucleotide reductase
  - ANT1 :: adenine nucleotide translocase type 1
  - OPA1 :: fusion
  - SERAC1 :: phosphatidylglycerol remodeling

[fn:narp] mtDNA-associated Leigh syndrome and NARP are part of a
continuum of progressive neurodegenerative disorders caused by
abnormalities of mitochondrial energy generation
[fn:pdh] Normal L/P ratio in PDH deficiency
[fn:mma] SUCLA2 and SUCLG1 deficiency
[fn:tk2] TK2 deficiency

* COMMENT Maintainance
#+CAPTION[]:Nuclear Gene Involved in Mitochondrial Maintainance
#+NAME: tab:ndna
#+ATTR_LATEX: :environment longtable :float sideways
| Gene                                   | Phenotype                                      | Inheritance |
|----------------------------------------+------------------------------------------------+-------------|
| *DNA replication/repair*               |                                                |             |
| POLG                                   | MCHS, Alpersâ€“Huttenlocher, ANS, adCPEO, arCPEO | AD, AR      |
| C10orf2                                | adCPEO, IOSCA, Epileptic encephalopathy        | AD, AR      |
| POLG2                                  | adCPEO, arCPEO                                 | AD          |
| DNA2                                   | adCPEO                                         | AD          |
| MGME1                                  | arCPEO, Myopathy                               | AR          |
| APTX                                   | Ataxia, Oculomotor apraxia                     |             |
|----------------------------------------+------------------------------------------------+-------------|
| *dNTP pools*                           |                                                |             |
| TYMP                                   | MNGIE                                          | AR          |
| DGUOK                                  | Hepatocerebral syndrome                        | AR          |
| TK2                                    | Myopathy, arCPEO, SMA phenocopy                | AR          |
| RRM2B*                                 | adCPEO, arCPEO, Myopathy, Tubulopathy          | AD, AR      |
| SUCLA2                                 | Encephalomyopathy (Leigh syndrome-like)        | AR          |
| SUCLG1                                 | Encephalomyopathy (Leigh syndrome-like)        | AR          |
| DUK1*                                  | Myopathy, hepatopathy                          | AR          |
| MPV17                                  | Encephalohepatopathy, Navajo neuroheptaopthy   | AR          |
|                                        | arCPEO                                         |             |
| ABAT                                   | Psychomotor retardation, seizures              | AR          |
|----------------------------------------+------------------------------------------------+-------------|
| *Mito network dynamics*                |                                                |             |
| OPA1                                   | Opticatrophy                                   | AD          |
| MFN2                                   | Peripheral neuropathy, optic neuropathy        | AR          |
|----------------------------------------+------------------------------------------------+-------------|
| *Mito transcription*                   |                                                |             |
| TRAM                                   | Hepatopathy, myopathy                          | AR          |
| *Mito protein synthesis & maintenance* |                                                |             |
| SPG7                                   | arCPEO                                         | AR          |
| AFG3L2                                 | arCPEO, ataxia                                 | AR          |
| *Mito protein import*                  |                                                |             |
| GFER                                   | Cataract, myopathy, sensorineural hearing loss | AR          |
| *Mito carrier transporters*            |                                                |             |
| SLC25A4                                | adCPEO, arCPEO, Myopathy, Cardiomyopathy       | AD, AR      |
| *Unclear functions*                    |                                                |             |
| FBXL4                                  | Encephalomyopathy,facialdysmorphism            | AR          |

- Abbreviations :: adCPEO, autosomal dominant chronic progressive
  external ophthalmoplegia; arCPEO, autosomal recessive chronic
  progressive external ophthalmoplegia; ANS, ataxia, neuropathy
  syndrome; IOSCA, infantile-onset spinocerebellar ataxia; MCHS,
  myocerebrohepatopathy syndrome; MNGIE, mitochondrial
  neurogastrointestinal encephalopathy; SMA, spinal motor atrophy.
